#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stevens-Johnson syndrome Desmoid tumour Fibrosarcoma metastatic Immunoglobulin G4 related disease Laryngeal squamous cell carcinoma Chronic myeloid leukaemia (in remission) Cardiac failure acute Adrenogenital syndrome Mucopolysaccharidosis III Familial hypertriglyceridaemia Myotonic dystrophy Hereditary optic atrophy Follicle centre lymphoma follicular grade I II – III refractory Inflammatory myofibroblastic tumour Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory Rosai-Dorfman syndrome – Diagnostics Chronic granulomatous disease – Life with Disease Rett syndrome – Diagnostics Choroid melanoma Progressive supranuclear palsy – Basic Information Propionic acidaemia Osteosarcoma – Treatment Toxic epidermal necrolysis – Diagnostics Rosai-Dorfman syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IMEROPRUBART GSK5784283 Losartan Potassium Evolocumab Taletrectinib Candesartan ENSIFENTRINE Atidarsagene Autotemcel Digoxin Enfuvirtide Teprenone Golexanolone Ht-29-B Treosulfan Mps-213 Asundexian Other Blood Products Iron Bp1.7881A Sodium Phenylbutyrate More therapies…

    Learn about Your Condition

    Erectile dysfunction Oedema peripheral Anal incontinence Abortion threatened Right ventricular dysfunction BRAF gene mutation Rectal cancer stage III Non-obstructive cardiomyopathy Neuroblastoma recurrent Kaposi's sarcoma Tumour of ampulla of Vater Oxygen saturation Viral myocarditis Papilloma viral infection Urticaria cholinergic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Alpelisib
    Croatia
  • Study on Propranolol for Preventing PTSD in Women After Sexual Violence

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Propranolol
    France
  • Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain
  • Study on Sirolimus and Prednisolone for Treating Superficial Arteriovenous Malformations in Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital arterial malformation
    Investigated Drugs:
    • Prednisolone Metasulfobenzoate Sodium
    • Sirolimus
    France
  • Study Comparing Laser Treatment and Tafluprost Eye Drops for Patients with Exfoliation Glaucoma or Ocular Hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Tafluprost
    Finland
  • Study on Eplerenone for Heart Health in Kidney Transplant Patients Using Cyclosporine or Tacrolimus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    France
Previous Page
1 … 831 832 833 834 835 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!